| Literature DB >> 30584247 |
Gyu-Hwi Nam1,2, Anshuman Mishra2, Jeong-An Gim3, Hee-Eun Lee1,2, Ara Jo1,2, Dahye Yoon4, Ahran Kim5, Woo-Jin Kim6, Kung Ahn7, Do-Hyung Kim5, Suhkmann Kim4, Hee-Jae Cha8, Yung Hyun Choi9, Chan-Il Park10, Heui-Soo Kim11,12.
Abstract
Olive flounder (Paralichthys olivaceus) is one of economically valuable fish species in the East Asia. In comparison with its economic importance, available genomic information of the olive flounder is very limited. The mass mortality caused by variety of pathogens (virus, bacteria and parasites) is main problem in aquaculture industry, including in olive flounder culture. In this study, we carried out transcriptome analysis using the olive flounder gill tissues after infection of three types of pathogens (Virus; Viral hemorrhagic septicemia virus, Bacteria; Streptococcus parauberis, and Parasite; Miamiensis avidus), respectively. As a result, we identified total 12,415 differentially expressed genes (DEG) from viral infection, 1,754 from bacterial infection, and 795 from parasite infection, respectively. To investigate the effects of pathogenic infection on immune response, we analyzed Gene ontology (GO) enrichment analysis with DEGs and sorted immune-related GO terms per three pathogen groups. Especially, we verified various GO terms, and genes in these terms showed down-regulated expression pattern. In addition, we identified 67 common genes (10 up-regulated and 57 down-regulated) present in three pathogen infection groups. Our goals are to provide plenty of genomic knowledge about olive flounder transcripts for further research and report genes, which were changed in their expression after specific pathogen infection.Entities:
Mesh:
Year: 2018 PMID: 30584247 PMCID: PMC6305387 DOI: 10.1038/s41598-018-36342-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Statistical summary of reads acquired from transcriptome analysis.
| Description | Samples | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U-I 1 | U-I 2 | U-I 3 | B-I 1 | B-I 2 | B-I 3 | V-I 1 | V-I 2 | V-I 3 | P-I 1 | P-I 2 | P-I 3 | |
|
| ||||||||||||
| Number of raw reads | 78,425,340 | 65,251,756 | 45,720,414 | 44,022,532 | 56,928,000 | 62,034,784 | 41,202,926 | 62,465,936 | 40,015,984 | 39,636,294 | 41,676,740 | 53,148,278 |
| Number of clean reads | 77,685,792 | 64,293,520 | 45,046,422 | 43,370,168 | 56,218,774 | 61,171,560 | 40,540,550 | 64,212,934 | 39,393,956 | 39,128,496 | 41,195,252 | 52,580,022 |
| Number of mapped reads | 35,293,624 | 34,011,030 | 21,768,778 | 23,241,737 | 25,467,484 | 26,640,040 | 25,215,623 | 37,509,022 | 19,159,186 | 6,587,353 | 13,259,405 | 11,685,297 |
| Number of uniquely mapped reads | 34,624,745 | 33,266,973 | 21,287,829 | 22,815,501 | 24,897,617 | 26,076,243 | 24,651,733 | 36,604,718 | 18,740,455 | 6,293,804 | 12,980,394 | 11,405,891 |
| Mapping rate of unique reads | 44.6% | 51.7% | 47.3% | 52.6% | 44.3% | 42.6% | 60.8% | 59.8% | 47.6% | 16.1% | 31.5% | 21.7% |
U-I: uninfected, B-I: bacteria-infected, V-I: virus-infected, P-I: parasite-infected.
The number of genes and transcripts identified from transcriptome analysis.
| Description | Samples | Summary | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U-I 1 | U-I 2 | U-I 3 | B-I 1 | B-I 2 | B-I 3 | V-I 1 | V-I 2 | V-I 3 | P-I 1 | P-I 2 | P-I 3 | ||
|
| |||||||||||||
| Known | 1,707 | 1,720 | 1,504 | 1,641 | 1,617 | 1,669 | 1,670 | 1,751 | 1,664 | 1,348 | 1,588 | 1,243 |
|
| Known (New Isoforms) | 18,564 | 18,567 | 18,561 | 18,562 | 18,564 | 18,567 | 18,563 | 18,568 | 18,563 | 18,539 | 18,563 | 18,501 |
|
| Novel | 19,380 | 19,527 | 19,066 | 19,474 | 19,338 | 19,495 | 19,528 | 19,547 | 19,461 | 18,443 | 19,287 | 17,765 |
|
| TOTAL | 39,651 | 39,814 | 39,131 | 39,677 | 39,519 | 39,731 | 39,761 | 39,866 | 39,688 | 38,330 | 39,438 | 37,509 |
|
|
| |||||||||||||
| Known | 25,572 | 25,078 | 24,574 | 24,900 | 25,079 | 24,966 | 24,479 | 24,618 | 24,189 | 23,061 | 24,516 | 22,945 |
|
| Novel | 93,402 | 93,533 | 93,017 | 93,505 | 93,345 | 93,513 | 93,532 | 93,527 | 93,416 | 92,260 | 93,297 | 91,281 |
|
| TOTAL | 118,974 | 118,611 | 117,591 | 118,405 | 118,424 | 118,479 | 118,011 | 118,145 | 117,605 | 115,321 | 117,813 | 114,226 |
|
U-I: uninfected, B-I: bacteria-infected, V-I: virus-infected, P-I: parasite-infected.
The number of DEGs after pathogens infection.
| Pathogen | Expression change to control | ||
|---|---|---|---|
| Up | Down | Total | |
| Virus | 1,364 | 11,051 | 12,415 |
| Bacteria | 720 | 1,034 | 1,754 |
| Parasite | 640 | 155 | 795 |
Figure 1Global gene expression changes after infection by three pathogens. Genes expression in uninfected control samples plotted versus genes expression in bacterial infected samples (A), in virus infected samples (B), and in parasite infected samples (C). Genes changed after pathogen infection are colored in red and green for upregulated and downregulated, respectively (p < 0.05).
Figure 2Distribution of DEGs in three pathogens group (bacteria, virus, and bacteria). Venn diagram show the number of DEGs among bacteria, virus, and parasite. 10 up-regulated and 57 down-regulated DEGs were overlapped in three pathogens group on common. The up-regulation of 1083 genes (virus), 408 genes (bacteria), and 561 genes (parasites). These genes were specific for each pathogen so can be used as candidate genes for vaccination or therapeutic agents. In case of the down-regulation of 10168 gene (virus), 177 gene (bacteria) and 60 gene (parasites) in infection of fish, these genes were specific for specific pathogens so can be used as a diagnosis marker for specific pathogens.
List of annotated DEGs among common gene after three pathogens infection.
| Gene Expression Change (Control → Infection) | Gene Accession | Description | Fold change (log2) (Bacteria/control) | Fold change (log2) (Virus/control) | Fold change (log2) (Parasite/control) | Predicted gene symbol |
|---|---|---|---|---|---|---|
| UP | GENE19852.r1 | Fibroblast growth factor 4 [Source:SWISS;Acc:P48804] | 0.658 | 0.661 | 0.782 | FGF4 |
| Down | GENE00707.r1 | Acidic mammalian chitinase [Source:SWISS;Acc:Q91XA9] | −0.540 | −1.386 | −1.367 | Chia |
| GENE16184.r1 | Rab GDP dissociation inhibitor beta [Source:SWISS;Acc:P50395] | −1.739 | −1.399 | −1.218 | GDI2 | |
| GENE11810.r1 | Neuronal acetylcholine receptor subunit alpha-7 [Source:SWISS;Acc:P22770] | −1.041 | −1.566 | −2.009 | CHRNA7 | |
| GENE04169.r1 | Histidine decarboxylase [Source:SWISS;Acc:P23738] | −1.177 | −1.173 | −1.266 | Hdc | |
| GENE11460 | Semaphorin-3E [Source:SWISS;Acc:O42237] | −1.454 | −2.466 | −1.203 | SEMA3E | |
| GENE21840.r1 | Cysteine-rich secretory protein LCCL domain-containing 1 [Source:SWISS;Acc:Q8CGD2] | −0.705 | −1.769 | −1.146 | Crispld1 | |
|
|
|
|
|
|
| |
| GENE06025.r1 | Protein phosphatase 1 regulatory subunit 3C-B [Source:SWISS;Acc:Q6P950] | −0.829 | −1.627 | −1.308 | ppp1r3cb | |
|
|
|
|
|
|
| |
| GENE18863 | 2-aminoethanethiol dioxygenase [Source:SWISS;Acc:Q6PDY2] | −1.029 | −2.165 | −1.399 | Ado | |
| GENE05041.r1 | AP-1 complex subunit sigma-3 [Source:SWISS;Acc:Q7TN05] | −1.146 | −1.544 | −1.340 | Ap1s3 | |
| GENE03465 | Homeobox protein Nkx-3.1 [Source:SWISS;Acc:Q99801] | −1.078 | −3.351 | −1.063 | NKX3-1 | |
| GENE24080.r1 | Transmembrane protein 205 [Source:SWISS;Acc:A1L2F6] | −0.743 | −2.695 | −0.980 | tmem205 | |
| GENE14826.r1 | Ethanolamine-phosphate phospho−lyase [Source:SWISS;Acc:Q7SY54] | −1.289 | −1.961 | −1.274 | etnppl | |
| GENE01095.r1 | Alcohol dehydrogenase 1 [Source:SWISS;Acc:P26325] | −0.750 | −1.348 | −0.906 | ADH1_GADMC | |
| GENE12085.r1 | Pyridine nucleotide-disulfide oxidoreductase domain−containing protein 2 [Source:SWISS;Acc:Q68FT3] | −0.953 | −1.658 | −0.839 | Pyroxd2 | |
| GENE22874.r1 | Potassium voltage-gated channel subfamily KQT member 3 [Source:SWISS;Acc:Q8K3F6] | −0.616 | −0.475 | −0.785 | Kcnq3 | |
| GENE06563 | Protein Hook homolog 3 [Source:SWISS;Acc:Q6GQ73] | −1.723 | −4.109 | −1.638 | hook3 | |
| GENE01318.r1 | Mitochondrial peptide methionine sulfoxide reductase [Source:SWISS;Acc:P54149] | −0.693 | −1.130 | −0.953 | MSRA | |
| GENE02237.r1 | Anterior gradient protein 3 homolog [Source:SWISS;Acc:Q8TD06] | −1.288 | −3.663 | −1.523 | AGR3 | |
| GENE11050.r1 | Viral T−cell receptor beta chain-like T17T-22 [Source:SWISS;Acc:P11364] | −1.211 | −3.670 | −1.053 | V-TCR | |
| GENE09774 | Claudin-12 [Source:SWISS;Acc:Q5R9K1] | −0.685 | −2.185 | −0.839 | CLDN12 | |
| GENE11823.r1 | Proline-rich protein 5-like [Source:SWISS;Acc:A2AVJ5] | −0.924 | −1.909 | −0.949 | Prr5l | |
|
|
|
|
|
|
| |
| GENE06547 | Krueppel-like factor 5 [Source:SWISS;Acc:Q9Z0Z7] | −1.264 | −2.379 | −1.251 | Klf5 | |
| GENE09838.r1 | Integrin alpha-10 [Source:SWISS;Acc:O75578] | −1.017 | −2.154 | −1.004 | ITGA10 | |
| GENE21626.r1 | Hydroxycarboxylic acid receptor 2 [Source:SWISS;Acc:Q8TDS4] | −1.033 | −2.299 | −1.053 | HCAR2 | |
| GENE01511.r1 | Ectonucleoside triphosphate diphosphohydrolase 5 [Source:SWISS;Acc:O75356] | −1.063 | −1.592 | −0.818 | ENTPD5 | |
| GENE15828.r1 | Matrix metalloproteinase-20 [Source:SWISS;Acc:O18767] | −1.145 | −2.128 | −0.738 | MMP20 | |
|
|
|
|
|
|
| |
| GENE01596.r1 | GTP cyclohydrolase 1 feedback regulatory protein [Source:SWISS;Acc:Q6PBT6] | −1.253 | −2.255 | −0.904 | gchfr | |
|
|
|
|
|
|
| |
| XLOC_002910 | Trypsin-1 [Source:SWISS;Acc:P35031] | −1.401 | −1.350 | −2.147 | TRY1_SALSA | |
|
|
|
|
|
|
| |
| XLOC_036089 | AT-hook-containing transcription factor [Source:SWISS;Acc:Q80VW7] | −1.577 | −2.290 | −1.507 | Akna | |
| XLOC_029355 | Collagen alpha-3(VI) chain [Source:SWISS;Acc:P15989] | −1.301 | −3.553 | −0.819 | COL6A3 |
*Six genes with asterisk are representive genes which have fold change (log2) of <−2.0 in at least two pathogen groups. p < 0.05.